3-179219562-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_006218.4(PIK3CA):c.1747-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000492 in 1,308,342 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00043 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00050 ( 0 hom. )
Consequence
PIK3CA
NM_006218.4 intron
NM_006218.4 intron
Scores
2
Splicing: ADA: 0.00009997
2
Clinical Significance
Conservation
PhyloP100: 0.433
Publications
0 publications found
Genes affected
PIK3CA (HGNC:8975): (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
PIK3CA Gene-Disease associations (from GenCC):
- overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- megalencephaly-capillary malformation-polymicrogyria syndromeInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- vascular malformationInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden syndrome 5Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 3-179219562-C-T is Benign according to our data. Variant chr3-179219562-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 246679.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000428 (65/151986) while in subpopulation NFE AF = 0.000795 (54/67930). AF 95% confidence interval is 0.000626. There are 0 homozygotes in GnomAd4. There are 25 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 65 AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PIK3CA | ENST00000263967.4 | c.1747-9C>T | intron_variant | Intron 11 of 20 | 2 | NM_006218.4 | ENSP00000263967.3 |
Frequencies
GnomAD3 genomes AF: 0.000428 AC: 65AN: 151986Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
65
AN:
151986
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000384 AC: 90AN: 234360 AF XY: 0.000407 show subpopulations
GnomAD2 exomes
AF:
AC:
90
AN:
234360
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000501 AC: 579AN: 1156356Hom.: 0 Cov.: 15 AF XY: 0.000544 AC XY: 320AN XY: 588178 show subpopulations
GnomAD4 exome
AF:
AC:
579
AN:
1156356
Hom.:
Cov.:
15
AF XY:
AC XY:
320
AN XY:
588178
show subpopulations
African (AFR)
AF:
AC:
4
AN:
27004
American (AMR)
AF:
AC:
5
AN:
41622
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
23504
East Asian (EAS)
AF:
AC:
0
AN:
38076
South Asian (SAS)
AF:
AC:
18
AN:
77884
European-Finnish (FIN)
AF:
AC:
0
AN:
52660
Middle Eastern (MID)
AF:
AC:
3
AN:
5068
European-Non Finnish (NFE)
AF:
AC:
532
AN:
840594
Other (OTH)
AF:
AC:
17
AN:
49944
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
27
54
80
107
134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000428 AC: 65AN: 151986Hom.: 0 Cov.: 32 AF XY: 0.000337 AC XY: 25AN XY: 74218 show subpopulations
GnomAD4 genome
AF:
AC:
65
AN:
151986
Hom.:
Cov.:
32
AF XY:
AC XY:
25
AN XY:
74218
show subpopulations
African (AFR)
AF:
AC:
8
AN:
41414
American (AMR)
AF:
AC:
0
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
1
AN:
5194
South Asian (SAS)
AF:
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
54
AN:
67930
Other (OTH)
AF:
AC:
1
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cowden syndrome 1 Benign:1
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jun 25, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Cowden syndrome Benign:1
Oct 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.